Meeting Highlights Information Registration Visa Letter Application Programme Overview Exhibition Virtual Exhibition Hotels Exhibition Virtual Exhibition Satellite Programme


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Association of keratoconus with osteogenesis imperfecta: about a case

Poster Details


First Author: B.Mrini MOROCCO

Co Author(s): F. Boudguigue   K. Madbouhi   M. Ikhloufi   N. Boutimzine   O. Cherkaoui        

Abstract Details

Purpose:

Osteogenesis imperfecta is a rare connective tissue disorder that is caused by a mutation in the two genes that encode the alpha chains of type 1 collagen. Its association with a keratocone is exceptional. We present here one case of this rare association.

Setting:

Ophthalmology A, Rabat Speciality Hospital, Morocco

Methods:

We report the case of a 9-year-old monophthalmic patient with an osteogenesis imperfecta treated with bisphosphonates. Ophthalmologic examination revealed a visual acuity at light perception (LP+), a microphthalmia, a corneal protrusion with an opacity, a congenital cataract, and at the fundus falciform retinal folds. The corneal topography confirmed the diagnosis of keratoconus. The congenital cataract has been operated and post-operative visual acuity was 1/10. The keratoconus has been first treated with a rigid corneal lens and then with a scleral lense and both has been poorly tolerated.Considering the bad prognosis because of retinal damage, corneal transplantation has not been performed.

Results:

Osteogenesis imperfecta is a disorder of bone fragility chiefly caused by mutations in the COL1A1 and COL1A2 genes that encode type I procollagen. Its association with a keratocone is exceptional. There is no correlation between the degree of corneal protrusion and the extent of bone disease.

Conclusions:

Although a rare outcome, the association of keratoconus with osteogenesis imperfecta should be considered and an ophthalmological examination must be systematically performed in patients with osteogenesis imperfecta.

Financial Disclosure:

None

Back to Poster listing